The effect of β-blockers on bone metabolism as potential drugs under investigation for osteoporosis and fracture healing
Authors:
- Dafydd Hammond-JonesDHDafydd Hammond-Jones
- Zakareya GamieZGZakareya Gamie
- Ioannis PolyzoisIPIoannis Polyzois
- Evgenios TsiridisETEvgenios Tsiridis
- Eleftherios TsiridisETEleftherios Tsiridis
- 12 August 2008
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 17 (9) , 1281-1299
Abstract
Background: β-Adrenergic receptor antagonists (β-blockers) have a well-recognised antihypertensive action that is mediated through a reduction in cardiac output and in the release of renin from the kidneys and inhibition of the action of endogenous catecholamines on β-adrenergic receptors. This class of drugs has been shown to reduce the incidence of cardiovascular disease. Recent evidence suggests that β-blockers may also have an effect on bone structure, metabolism and fracture healing. Objective: This paper reviews in vitro and in vivo data that suggest β-blockers have primarily an anabolic effect on bone metabolism. Results: The sympathetic nervous system has a catabolic effect on bone, and in vitro studies have shown that adrenergic agonists stimulate bone resorption. The β-blocker propranolol has been shown to increase bone formation in ovariectomised female rats. Also, recent observational clinical studies provide evidence to show that β-blockers are associated with reduction in fracture risk in bo...Keywords
This publication has 75 references indexed in Scilit:
- Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational studyBMJ, 2007
- Use of β-Blockers and the Risk of Hip/Femur Fracture in the United Kingdom and The NetherlandsCalcified Tissue International, 2007
- Combined treatment with a β-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized miceBone, 2006
- β-Blocker Use, BMD, and Fractures in the Study of Osteoporotic FracturesJournal of Bone and Mineral Research, 2005
- Chemical sympathectomy‐induced changes in TH‐, VIP‐, and CGRP‐immunoreactive fibers in the rat mandible periosteum: Influence on bone resorptionJournal of Cellular Physiology, 2003
- Epidemiology and outcomes of osteoporotic fracturesThe Lancet, 2002
- A neuro (endo)crine regulation of bone remodelingBioEssays, 2000
- Interleukin-11 inhibits bone formation in vitroCalcified Tissue International, 1993
- Prostaglandin E2 stimulates DNA synthesis by a cyclic AMP‐independent pathway in osteoblastic clone MC3T3‐E1 cellsJournal of Cellular Physiology, 1986
- Involutional OsteoporosisNew England Journal of Medicine, 1986